SCHEMBL24022650

SCHEMBL24022650

CCc1ccc(-c2cccc(C)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.56
CCR8 P51685 1/20 0.56
RAB9A P51151 6/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
CYP2A6 P11509 1/20 0.49
BRS3 P32247 1/20 0.48
METAP2 P50579 2/20 0.44
MAPT P10636 5/20 0.44
NPC1 O15118 4/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
HIF1A Q16665 1/20 0.44
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3631394 0.88 RAB9A (0.52) RAB9ASMN1; SMN2METAP2MAPTNPC1
SCHEMBL3422361 0.85 CCR1 (0.75) CCR1CCR8RAB9ACYP2A6METAP2
SCHEMBL12970400 0.83 CCR1 (0.54) CCR1CCR8RAB9ACYP2A6BRS3
SCHEMBL171757 0.80 CCR1 (0.50) CCR1CCR8RAB9ACYP2A6BRS3
SCHEMBL2614970 0.79 CCR1 (0.65) CCR1CCR8RAB9ASMN1; SMN2CYP2A6
SCHEMBL12170347 0.79 ASIC3 (0.60) RAB9ASMN1; SMN2BRS3METAP2MAPT
SCHEMBL19407092 0.79 RAB9A (0.44) RAB9ASMN1; SMN2METAP2MAPTNPC1
SCHEMBL12270035 0.79 CCR1 (0.48) CCR1CCR8RAB9ACYP2A6BRS3
SCHEMBL12318156 0.79 CCR1 (0.48) CCR1CCR8CYP2A6BRS3METAP2
SCHEMBL2189142 0.78 KMT2A (0.62) CCR1CCR8RAB9ACYP2A6METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3509589-B1 NOVEL USES INTRA CELLULAR THERAPIES INC (US) 2021-11-17 EP disclosed